09:35 EDT Xilio Therapeutics (XLO) files $250M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics reports Q4 EPS (20c) vs (64c) last year
- Biotech Alert: Searches spiking for these stocks today
- Xilio Therapeutics: Innovative TCE Platform and Strategic AbbVie Partnership Justify Buy Rating
- Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie
- Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue